Spirometry use: Detection of chronic obstructive pulmonary disease in the primary care setting

Clinical Interventions in Aging

Volumn 6, Issue 1, 2011, Pages 47-52

  Barnes, Thomas A ^a   Fromer, Len ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Family practice; Primary care physician; Spirometry

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; ELECTRICAL EQUIPMENT; FORCED EXPIRATORY VOLUME; FORCED EXPIRATORY VOLUME FORCED VITAL CAPACITY RATIO; GENERAL PRACTICE; HEALTH CARE PRACTICE; HUMAN; MASS SCREENING; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PORTABLE EQUIPMENT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RESPIRATORY TRACT PARAMETERS; REVIEW; SAFETY; SPIROMETRY; STAGING; AGED; AGING; METHODOLOGY; PRIMARY HEALTH CARE;

AGED; AGING; FAMILY PRACTICE; HUMANS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 80051634527     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S15164     Document Type: Review

References (39)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, 2009. Available from: http://www.goldcopd.org. Accessed Jan15 2010.
2. Petty TL. John Hutchinson's mysterious machine revisited. Chest. 2002;121 Suppl 5:S219-S223.
3. Chavannes N, Schermer T, Akkermans R, et al. Impact of spirometry on GPs' diagnostic differentiation and decision-making. Respir Med. 2004;98(11):1124-1130.
4. Dales RE, Vandemheen KL, Clinch J, et al. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest. 2005;128(4):2443-2447.
5. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J. 2007;30(4):616-622.
6. Yawn BP, Enright PL, Lemanske RF Jr, et al. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162-1168.
7. Lin K, Watkins B, Johnson T, et al. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2008;148(7):535-543.
8. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402-407.
9. Lusuardi M, de Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129(4):844-852.
10. Buffels J, Degryse J, Decramer M, et al. Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med. 2006;100(11):2012-2017.
11. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good? Chest. 2006;129(4):833-835.
12. Stratelis G, Molstad S, Jakobsson P, et al. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006;24(3):133-139.
13. Tashkin DP, Murray RP. Smoking cessation in chronic obstructive pulmonary disease. Respir Med. 2009;103(7):963-974.
14. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742-750.
15. McCormack MC, Enright PL. Making the diagnosis of asthma. Respir Care. 2008;53(5):583-590; discussion 590-592.
16. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care. 2009;54(8):1040-1049.
17. Macintyre NR. Spirometry for the diagnosis and management of chronic obstructive pulmonary disease. Respir Care. 2009;54(8):1050-1057.
18. O'Donnell DE, Laveneziana P, Ora J, et al. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax. 2009;64(3):216-223.
19. Goodfellow LT, Waugh JB. Tobacco treatment and prevention: what works and why. Respir Care. 2009;54(8):1082-1090.
20. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332-338.
21. Restrepo RD. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review. Respir Care. 2009;54(8):1058-1081.
22. Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med. 1995;333(11):710-714.
23. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793.
24. Fishman A, Martinez F, Naunheim K, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lungvolume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059-2073.
25. Leuppi JD, Miedinger D, Chhajed PN, et al. Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration. 2010;79(6):469-474.
26. Yawn B, Mannino D, Littlejohn T, et al. Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin. 2009;25(11):2671-2677.
27. US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(7):529-534.
28. COPD Foundation. Mobile spirometry unit, 2010. Available from: http://www.copdfoundation.org/Programs/MobileSpirometryUnit/tabid/104/language/en-US/Default.aspx. Accessed Nov 24 2010.
29. Nelson SB, Thomashaw BM, Enright P, et al. A tiered, economical approach for COPD case-finding in the general population. Am J Respir Crit Care Med 2010;181:A5949.
30. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85-95.
31. Lamprecht B, Schirnhofer L, Tiefenbacher F, et al. Six-second spirometry for detection of airway obstruction: a population-based study in Austria. Am J Respir Crit Care Med. 2007;176(5):460-464.
32. The National Lung Health Education Program (NLHEP). Strategies in preserving lung health and preventing COPD and associated diseases. Chest. 1998;113 Suppl 2:S123-S163.
33. White P. Spirometry and peak expiratory flow in the primary care management of COPD. Prim Care Respir J. 2004;13(1):5-8.
34. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121 Suppl 5:S121-S126.
35. American Association for Respiratory Care Dallas Texas. National Lung Health Education Program-Spirometer Review Process, 2007. Available from: http://www.nlhep.org/spirometer-review-process.html. Accessed 2010 Nov 24.
36. Vitalograph Ltd Buckingham England. Electronic peak flow meters, 2009. Available from: http://www.vitalograph.co.uk/products/asma-1.php. Accessed Nov 24 2010.
37. Enright PL. How to make sure your spirometry tests are of good quality. Respir Care. 2003;48(8):773-776.
38. Engstrom CP, Persson LO, Larsson S, et al. Reliability and validity of a Swedish version of the St. George's Respiratory Questionnaire. Eur Respir J. 1998;11(1):61-66.
39. Stallberg B, Nokela M, Ehrs PO, et al. Validation of the Clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes. 2009;7:26.